(2S,5S,11S,12R,15S,18S,21R,27S)-11-((S)-2-((R)-4-Amino-2-((S)-2-decanamido-3-(1H-indol-3-yl)propanamido)-4-oxobutanamido)-3-carboxypropanamido)-15-(2-(2-aminophenyl)-2-oxoethyl)-27-(2-aminopropanamido)-5-(3-aminopropyl)-18-((R)-1-carboxypropan-2-yl)-21-(hydroxymethyl)-12-methyl-4,7,10,14,17,20,23,26-octaoxo-13-oxa-3,6,9,16,19,22,25-heptaazaoctacosane-1,2,28-tricarboxylic Acid
Product Name |
(2S,5S,11S,12R,15S,18S,21R,27S)-11-((S)-2-((R)-4-Amino-2-((S)-2-decanamido-3-(1H-indol-3-yl)propanamido)-4-oxobutanamido)-3-carboxypropanamido)-15-(2-(2-aminophenyl)-2-oxoethyl)-27-(2-aminopropanamido)-5-(3-aminopropyl)-18-((R)-1-carboxypropan-2-yl)-21-(hydroxymethyl)-12-methyl-4,7,10,14,17,20,23,26-octaoxo-13-oxa-3,6,9,16,19,22,25-heptaazaoctacosane-1,2,28-tricarboxylic Acid
|
Product Code |
DA-D029-25
|
Chemical name |
(2S,5S,11S,12R,15S,18S,21R,27S)-11-((S)-2-((R)-4-Amino-2-((S)-2-decanamido-3-(1H-indol-3-yl)propanamido)-4-oxobutanamido)-3-carboxypropanamido)-15-(2-(2-aminophenyl)-2-oxoethyl)-27-(2-aminopropanamido)-5-(3-aminopropyl)-18-((R)-1-carboxypropan-2-yl)-21-(hydroxymethyl)-12-methyl-4,7,10,14,17,20,23,26-octaoxo-13-oxa-3,6,9,16,19,22,25-heptaazaoctacosane-1,2,28-tricarboxylic Acid
|
Synonyms |
1,2,28-Tricarboxylic Acid, (2S,5S,11S,12R,15S,18S,21R,27S)-11-((S)-2-((R)-4-amino-2-((S)-2-decanamido-3-(1H-indol-3-yl)propanamido)-4-oxobutanamido)-3-carboxypropanamido)-15-(2-(2-aminophenyl)-2-oxoethyl)-27-(2-aminopropanamido)-5-(3-aminopropyl)-18-((R)-1-carboxypropan-2-yl)-21-(hydroxymethyl)-12-methyl-4,7,10,14,17,20,23,26-octaoxo-13-oxa-3,6,9,16,19,22,25-heptaazaoctacosane-; Daptomycin Impurity 1;
|
Impurity |
NA
|
CAS Number |
NA
|
Alternate CAS # |
NA
|
Molecular form |
C72H103N17O27
|
Appearance |
NA
|
Melting Point |
NA
|
Mol. Weight |
1638.69
|
Storage |
2-8°C Refrigerator
|
Solubility |
NA
|
Stability |
NA
|
Category |
chiral standards,heterocycles,pharmaceutical standards,intermediates,fine chemicals
|
Boiling Point |
NA
|
Applications |
NA
|
Dangerous Goods Info |
NA
|
References |
NA
|
Extra Notes |
NA
|
Documents (MSDS) |
No Data Available
|
Keywords |
NA |